Although diabetes is a common condition, no cure exists yet. Current therapies can manage blood sugar levels, but they do not address insulin resistance. But now, recent research reported in ACS Nano shows that targeting certain highly reactive molecules in the liver can reverse insulin resistance in human liver cells and diabetic mice, providing a pathway toward a more long-lasting treatment.
Click here for original story, Biodegradable nanoscavengers can reverse insulin resistance in liver cells to treat type 2 diabetes
Source: Phys.org